Non-hemodynamic effects: Repurposing of nonselective beta-blockers in cirrhosis?

被引：5
|
作者：
Yang, Yi [1 ,2 ]
Li, Mingkai [1 ,3 ]
Luo, Jinni [1 ,3 ]
Yu, Hongsheng [1 ,3 ]
Tian, Hong [1 ,3 ]
Wang, Xing [1 ,3 ]
机构：
[1] Sun Yat Sen Univ, Dept Gastroenterol, Affiliated Hosp 3, 600 Tianhe Rd, Guangzhou 510630, Peoples R China
[2] Xizang Minzu Univ, Sch Med, Xianyang, Peoples R China
[3] Guangdong Prov Key Lab Liver Dis Res, Guangzhou, Peoples R China
来源：
PORTAL HYPERTENSION & CIRRHOSIS | 2022年 / 1卷 / 02期
基金：
中国国家自然科学基金;
关键词：
SURVIVAL;
D O I：
10.1002/poh2.22
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：153 / 156
页数：4
相关论文
共 44 条
  • [1] ELECTRIC AND HEMODYNAMIC EFFECTS OF BETA-BLOCKERS IN PATIENTS WITH LIVER CIRRHOSIS
    Tieranu, Eugen
    Donoiu, Ionut
    Istratoaie, Octavian
    Tieranu, Loredana Maria
    Gheonea, Dan-Ionut
    Ciurea, Tudorel
    Ghenea, Alice Elena
    Ungureanu, Anca
    FARMACIA, 2020, 68 (05) : 843 - 848
  • [2] Is Hydrophobia Necessary for the Hepatologist Prescribing Nonselective Beta-Blockers in Cirrhosis?
    Senzolo, Marco
    Nadal, Elena
    Cholongitas, Evangelos
    Burroughs, Andrew K.
    HEPATOLOGY, 2011, 53 (06) : 2149 - 2150
  • [3] Safety of Nonselective Beta-Blockers in Decompensated Liver Cirrhosis and Their Role in Inducing Hepatorenal Syndrome
    Qaqish, Faris
    Dimachkie, Reem
    Sasso, Roula
    Loeffler, Jeffrey
    Hasan, Mohammed
    Deghani, Shabnam
    Yassine, Ahmad Abou
    Deeb, Liliane
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [4] Beta-Blockers in Cirrhosis: Friend and Foe?
    Wong, Florence
    Salerno, Francesco
    HEPATOLOGY, 2010, 52 (03) : 811 - 813
  • [5] Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites
    Ferrarese, Alberto
    Tikhonoff, Valerie
    Casiglia, Edoardo
    Angeli, Paolo
    Fasolato, Silvano
    Faggian, Diego
    Zanetto, Alberto
    Germani, Giacomo
    Russo, Francesco Paolo
    Burra, Patrizia
    Senzolo, Marco
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [6] Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies
    Massalee, Rachel
    Cao, Xuefang
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [7] Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity?
    Nabilou, Puria
    Danielsen, Karen Vagner
    Kimer, Nina
    Hove, Jens Dahlgaard
    Bendtsen, Flemming
    Moller, Soren
    PLOS ONE, 2022, 17 (06):
  • [8] Beta-Blockers in Patients with Cirrhosis and Refractory Ascites
    Albillos, Agustin
    Zamora, Javier
    HEPATOLOGY, 2011, 53 (05) : 1783 - 1783
  • [9] Non-selective beta-blockers are not associated with serious infections in veterans with cirrhosis
    Bajaj, J. S.
    Ratliff, S. M.
    Heuman, D. M.
    Lapane, K. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 38 (04) : 407 - 414
  • [10] Beta-blockers in the era of precision medicine in patients with cirrhosis
    Albillos, Agustin
    Krag, Aleksander
    JOURNAL OF HEPATOLOGY, 2023, 78 (04) : 866 - 872
12345